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Abstract
Grimace scales quantify characteristic facial expressions associated with spontaneous pain in rodents and other mammals.
However, these scales have not been widely adopted largely because of the time and effort required for highly trained
humans to manually score the images. Convoluted neural networks were recently developed that distinguish individual
humans and objects in images. Here, we trained one of these networks, the InceptionV3 convolutional neural net, with a
large set of human-scored mouse images. Output consists of a binary pain/no-pain assessment and a confidence score.
Our automated Mouse Grimace Scale integrates these two outputs and is highly accurate (94%) at assessing the presence of
pain in mice across different experimental assays. In addition, we used a novel set of “pain” and “no pain” images to show
that automated Mouse Grimace Scale scores are highly correlated with human scores (Pearson’s r¼ 0.75). Moreover, the
automated Mouse Grimace Scale classified a greater proportion of images as “pain” following laparotomy surgery
when compared to animals receiving a sham surgery or a post-surgical analgesic. Together, these findings suggest that the
automated Mouse Grimace Scale can eliminate the need for tedious human scoring of images and provide an objective and
rapid way to quantify spontaneous pain and pain relief in mice.
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Introduction
Despite a persistent demand for new analgesics with
fewer adverse side effects, successes in translating basic
discoveries into clinical treatments have been limited.
Standard tests of animal hypersensitivity and allodynia
do not measure spontaneous pain—the main symptom
associated with chronic pain in humans.1–3 In an attempt
to address this mismatch, assays that monitor ongoing
spontaneous pain in rodents were developed, although
many of these assays have uncertain predictive value (see
Mogil4). Moreover, a significant proportion of sponta-
neous pain assays are prohibitively labor-intensive to
score and require highly trained personnel.
The Mouse and Rat Grimace Scales (MGS and RGS)
measure characteristic changes in facial expressions that
associate with pain in rodents.5,6 To make use of these
scales, close-up video is obtained from rodents, individ-
ual images containing the face are manually extracted,
and the images are scored for the presence or absence of
grimacing, as defined by changes in facial musculature.
This rodent scale is based on human facial coding
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scales.7,8 Facial grimace scales were subsequently
adapted to detect spontaneous pain in additional species
including sheep,9,10 horses,11,12 rabbits,13 cattle,14 pigs,15
and cats.16 Researchers used this scoring system to
evaluate analgesic efficacy in mice17 and rats,18,19,20,21
as well as evaluate post-surgical spontaneous pain in
rodents.22,23 To eliminate the need for manual image
extraction, the Rodent Face FinderVR software was devel-
oped. This software identifies and extracts video frames
when mice or rats are facing the camera.6,17 However,
this software does not eliminate two of the most time-
consuming and subjective aspects of using grimace
scales—(1) training lab personnel to score images and
(2) scoring the large numbers of images that are gener-
ated as part of each experiment. Widespread adoption of
grimace scales has been limited as a result, despite
the fact these scales are reproducible between labs and
accurately predict analgesic efficacy.
We reasoned that a machine learning model could be
used to eliminate the need for humans to score images.
To test this possibility, we trained and optimized a
convolutional neural network based on Google’s
InceptionV3 model24 to analyze and classify a large
number of “pain” and “no pain” face images from out-
bred CD-1 mice. Similar machine-learning models were
used to predict human self-reported pain25,26 and to clas-
sify changes in mouse behavior at the sub-second level.27
Our automated Mouse Grimace Scale (aMGS) was val-
idated on novel image sets generated in two different
labs (Zylka and Mogil) and accuracy was compared to
human scoring. In contrast to previous efforts,28 we
show a consistently high accuracy across large data
sets that include high-definition color images procured
from multiple pain tests. Finally, we evaluate the
predictive validity of our model using an assay of
post-operative pain (laparotomy) and relief of pain
with carprofen, a non-steroidal anti-inflammatory
drug. This analgesic was previously found to reduce
pain-induced grimacing in mice and rats when images
were scored by humans.17,21
Methods
Animals
All animal experiments were approved by the
Institutional Animal Care and Use Committee of the
University of North Carolina at Chapel Hill and in
accordance with NIH guidelines. Archived images
from the Mogil lab were of mice previously tested in
compliance with the McGill Downtown Animal Care
and Use committee and were consistent with Canadian
Council on Animal Care guidelines. Images of mice were
obtained from video or still image archives kept at the
Mogil lab at McGill University (Quebec, Canada) or
recorded and processed at the University of North
Carolina (Chapel Hill, NC, USA). All animals used in
this study were CD-1
VR
(ICR:Crl) mice (6–12 weeks old)
and were purchased from Charles River Laboratories
(Albany, NY; St. Constant, QC). Mice at UNC were
housed in standard 7.5 in. 11.5 in. 5 in. polycarbon-
ate cages with 1/4-in. corncob bedding (Bed-o’Cobs,
Maumee, OH) in groups of five with same-sex litter-
mates under a 12:12-h light:dark cycle (lights on at
07:00), in a temperature-controlled environment (20
 1C), and with ad libitum access to food (Envigo
Teklad 2920, Harlan Teklad) and tap water. Each
animal underwent one surgery (and/or drug or anesthe-
sia exposure). Mice received isoflurane during surgery
and were sacrificed immediately after post-surgical
observation. In cases of surgical complications, mice
were immediately sacrificed without further testing.
Roughly equal numbers of male and female mice were
tested in each cohort. Neither main effects of sex nor
interactions with sex were noted, so collapsed data
are reported.
Compounds
Zymosan was obtained from Sigma-Aldrich (St. Louis,
MO) and dissolved in physiological saline (5.0 mg/ml),
and unilaterally injected (20ml volume) into the
intraarticular space around the ankle joint. Carprofen
(Rimadyl
VR
) was purchased from Zoetis, Inc.
(Kalamazoo, MI) and administered to a subset of animals
(50 mg/kg, s.c.) as described below.
Video capture
Data sets provided from the Mogil lab were generated
by placing mice individually on a tabletop in cubicles
(9 5 5 cm high) with two walls of transparent
Plexiglas and two side walls of removable stainless
steel. Two high-resolution (1920 1080) digital video
cameras (High-Definition Handycam Camcorder,
model HDR-CX100, Sony, San Jose, CA) were placed
immediately outside both walls to maximize the oppor-
tunity for clear head shots (see Figure 1(a)). Video was
taken for 30 min immediately before zymosan ankle
injection (baseline) and for 30-min periods at various
time points after injection.
To generate additional images for our training set, as
well as validate the classification accuracy of the aMGS,
additional mice were filmed using a second experimental
assay. Mice were placed individually on the edge of a
tabletop in a custom-built four-cubicle array (each cubi-
cle measuring 5 12 6 cm high) with one back wall of
transparent acrylic glass and two side walls of stainless
steel (see Figure 1(b)). The fourth wall was open and
positioned directly above the floor (1.1-m drop).
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We found that this arrangement encourages mice to look
towards the visual cliff and hence face the camera. One
camera was positioned 0.25 m away from the open side
to capture video footage mice in the cubicle array. In this
configuration, four mice can be recorded simultaneously
using two high-resolution (1920 1080) digital video
cameras (High-Definition Camcorder, model HFR700,
Canon, Tokyo, Japan). After a 30-min habituation to
the cubicle, mice were filmed for a 30-min baseline ses-
sion immediately before surgery or inter-articular zymo-
san injection.
Nociceptive assays
We obtained scored mouse grimace image sets from the
Mogil lab to create our initial training set. These images
were generated as part of a previous study,5 and repre-
sent data from multiple pain tests. We also used the
intrarticular zymosan inflammation assay (ZYM) to
supplement the initial training image set as well as gen-
erate a separate set of images to serve as a novel valida-
tion set (not used in the initial training). We used this
second validation set to compare automated and human
image classification. ZYM consisted of a single 20
ll injection of 5 mg/ml zymosan into the right ankle
joint. Mice were allowed to recover for 3 h in their
home cage after injection and before being placed back
into our video setup for a 30-min habituation prior to
filming. Mice were filmed for 1 h.
A post-surgical pain assay (laparotomy, LAP) is
designed to mimic a ventral ovariectomy. We used the
LAP test to further validate the aMGS as a second pain
assay, as well as evaluate our system’s ability to detect
analgesia-related reduction in mouse grimacing. LAP
surgeries were performed on isoflurane–oxygen-anesthe-
tized mice by a single surgeon (AHT). After shaving and
disinfection of the surgical site, a 1-cm midline incision
was made by using a scalpel. Muscle layers and skin
edges were closed with 6-0 non-absorbable braided silk
suture and skin edges apposed by using tissue glue. Once
recovered from anesthesia, mice were reintroduced to
video cubicles to obtain post-surgical video recordings.
Mice (n¼ 64) were placed into one of three groups: (1)
surgery alone (laparotomy); (2) surgery plus carprofen
(50 mg/kg, s.c.) during recovery (carprofen); (3) isoflur-
ane anesthesia and surgery preparation only (sham
surgery). All surgeries were performed at 13:00 1 h.
Cases of excessive bleeding or poor surgical outcome
were excluded from testing (n¼ 7). Mice were allowed
to recover for 15–20 min following surgery before being
filmed for 1 h in the video rig.
Image generation and human scoring
Individual frames from video files were “grabbed” auto-
matically by the Rodent Face Finder software, devel-
oped previously to assist in capturing mouse and rat
face images from video.6,17 This software detects
frames, in an unbiased fashion, where eyes and ears
are visible and image quality is not compromised by
motion blurring. The Rodent Face Finder was set
to grab one image for every 10 s of video in order to
avoid oversampling extremely short observation periods.
All images were output from the software and placed
into Microsoft PowerPoint, with one image per slide.
A PowerPoint macro (http://www.tusharmehta.com/
powerpoint/randomslideshow/index.htm) was used to
randomize the slide order. Identifications were removed
to ensure that subsequent coding was performed in a
blinded fashion by experienced human scorers.
Randomized and unlabeled photos were presented
sequentially on a large, high-resolution computer moni-
tor. For each photo, the scorer assigned a value of 0, 1,
or 2 for each of the five MGS action units: (1) orbital
tightening, (2) nose bulge, (3) cheek bulge, (4) ear posi-
tion, and (5) whisker change. In each case, a score of 0
indicated high confidence by the scorer that the action
unit was absent. A score of 1 indicated either high
confidence of a moderate appearance of the action unit
or equivocation over its presence or absence. A score of
Figure 1. Setups used to capture continuous video footage of mice. Examples of mice grimacing in (a) the traditional recording setup with
mice enclosed in Plexiglas boxes and (b) the new elevated cliff recording setup. Mice face towards the visual cliff for most of the recording
session in the new setup, allowing the use of a single camera instead of two cameras. The camera also captures clearer images (without
reflections) through air than through the Plexiglas partition.
Tuttle et al. 3
2 indicated high confidence of a marked appearance of
the action unit. The final MGS score was the summed
score across the five action units (resulting in a maxi-
mum hypothetical score of 10 and minimum score of
0). All human scores were input into our initial training
set for the automated scoring system.
The automated Mouse Grimace Scale
To systematically classify an individual mouse facial
expression as “pain” or “no pain,” the InceptionV3
convolutional neural net—one of the current standard
convolutional neural net’s for generalized image classifi-
cation—was retrained on our own data set. We began by
building the initial training set from a combination of
previously published pain images (provided by the Mogil
lab5) and supplemented by additional ZYM images
generated in the Zylka lab. Altogether, our training set
comprised 5,771 unique images: 2,444 “pain” and 3,327
“no pain.” We then validated our model by combining
unpublished ZYM images from the Mogil lab (scored by
SGS) and adding annotated laparotomy images generat-
ed by the Zylka lab (scored by JJ). To determine inter-
rater reliability, we calculated a concordance value based
on MGS scores produced by our human raters on a
subset of training images. We found our two MGS scor-
ers to be in close agreement with one another on the
same set of ZYM images (Cronbach’s alpha¼ 0.89).
Initial training images were selected equally from
published data sets as well as new experiments in order
to maximize image heterogeneity. This was to ensure
that our model would be able to classify pain faces
across a variety of different testing parameters (including
image background, image quality, rodent facial differ-
ences, and pain assays). We confirmed the absence of
large systematic differences between “pain” and “no
pain” images using a pixel-by-pixel structural similarity
analysis on a subset of our training images (n¼ 12–16).
Analysis revealed that within-group and between-group
differences were statistically indistinguishable from
one another.
To further anticipate future variations in image qual-
ity, a random selection of “pain” images from the train-
ing set were duplicated, programmatically altered by
cropping ( up to 10% on each side), horizontal flip-
ping, or brightness scaling by a factor of N(1,0.2), and
then added back into the “pain” image subset. By alter-
ing some of the pain images, we were also able to create
an overall balanced training set (3,536 “pain” and 3,326
“no pain” images). Both the training and classification
scripts utilized Google’s TensorFlow (v1.0) library and
were written in Python (v3.5). To tailor the pre-trained
model for our specifications, we exploited the power of
transfer learning to retrain only the final fully connected
and softmax layers of the inception model on our own
training image set.
To train the model, we split our balanced training set
(comprising 6,862 total images) into training (80%), test-
ing (10%), and validation (10%) subsets. After empiri-
cally testing various training hyper-parameters, we
found a learning rate of 0.01 to be ideal. The training
batch size was set to 100 images, and the batch size for
both testing and validation sets remained unbounded in
order to balance the stability of results between training
runs. The model trained to converge after 7,500 itera-
tions of 100-image training batches processed by our
neural network.
The aMGS was designed to output a classification
(“pain” or “no pain”) and respective confidence rating
(from 0.5 to 1.0). High-confidence images determined by
a confidence rating above a specified threshold were
retained and classified, while low-confidence images
were discarded. This increased the model’s accuracy
while simultaneously serving as a quality control step
to further identify and remove low-quality images.
Model training and image classification was completed
on standard notebook computers (Macbook Pro mid-
2015, Palo Alto, CA, and Dell Inspiron 15 7000 series
mid-2016, Round Rock, TX).
Laparotomy experiment
To test the predictive validity of our new model, we
processed novel images obtained from animals undergo-
ing a laparotomy (with or without analgesia) or sham
surgery (control) using the aMGS. Our new model clas-
sified an image as either “pain” or “no pain” with an
accompanying confidence score. High-confidence images
were then selected (0.75 confidence or greater) and clas-
sified by our automated system. After identifying and
selecting high-confidence images, videos that did not
contain a minimum number of high-confidence images
(mean image number¼ 1 image/minute) were excluded
from analysis (n¼ 16–19). Spontaneous mouse pain was
quantified by taking a percentage: % “pain”= (“pain”
images/total images) 100. To compare degree of spon-
taneous mouse pain following surgery versus baseline, a
simple difference score was calculated: % pain(post-sur-
gery)% pain(baseline).
Statistics
All statistical analyses were performed using Systat v.13
(SPSS, Chicago, IL), with a criterion of a¼ 0.05.
To compare human and machine grimace scores, a
linear regression analysis was performed between
images that were rated by two coders (SGS or JJ) on
the 11-point MGS compared with the confidence
rating of the aMGS. To measure human inter-rater
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concordance, Cronbach’s a was calculated on coder
scores from the same set of 275 sample mouse images.
Human versus machine scores were compared using a
simple linear regression; machine confidence intervals
were compared to chance levels using one-sample t-
tests followed by Bonferroni correction. For the laparot-
omy experiment, normality and homoscedasticity were
confirmed using the Anderson-Darling and Levene tests,
respectively, and parametric statistics were used in all
cases. Baseline behavioral outliers were identified
(Studentized residual> 3.0) and removed prior to final
analysis (n¼ 2). Group data were analyzed by one-way
analysis of variance (ANOVA), followed by Tukey’s
Test to determine group differences.
Results
The aMGS shows a high degree of internal accuracy
After training the aMGS, we reran the original dataset
through the trained model and checked preliminary clas-
sification results. We found that when every training
image was included for analysis, the model’s calculated
sensitivity (79%), specificity (87.2%), and accuracy
(83%) were suboptimal as compared to experienced
human coders. To increase the model’s accuracy, we
used the confidence interval output generated automat-
ically by the aMGS to eliminate “ambiguous” images.
Specifically, we restricted subsequent analysis to high-
confidence (>0.75 confidence interval) images. After
recalculation, the same metrics were significantly
improved: sensitivity (90.5%), specificity (96.1%), and
accuracy (93.2%) (Table 1).
We next validated the aMGS using a reserved subset
(10%) of our initial image pool that was not used to
train the model (“validation set”). After analyzing the
entirety of the validation set, the aMGS achieved an
accuracy of 84%. To increase the model’s classification
accuracy, we once again restricted the aMGS to analyze
only high-confidence images from the validation set
(>0.75 confidence interval). This increased the model’s
reported accuracy to 94%, which is comparable to what
highly experienced human coders achieve.5,17
Classification accuracy of the aMGS and
human coders is comparable when presented
with novel images
To further validate the aMGS, we acquired unpublished
images of mice at baseline or after receiving ankle zymo-
san injections scored by the Mogil lab (SGS, using the
standard cubicle system; Figure 1(a)) and combined
them with additional baseline and ankle zymosan
images generated and scored by the Zylka lab using
our new cubicle system (JJ, Figure 1(b)). The collective
image set (total n¼ 433) was analyzed by the aMGS and
assigned a classification (“pain” or “no pain”) as well as
a confidence rating (0.5 to 1.0). We then compared these
confidence ratings against human MGS scores and
found a positive linear relationship between machine
and human scores (Pearson’s r¼ 0.75). One-sample
t-tests reveal that aMGS confidence ratings were signif-
icantly different from chance for every human MGS
score except “3,” although it is apparent that the
aMGS, as might be expected, had more difficulty classi-
fying intermediate MGS scores (reflected by a lower
confidence rating) than images that garnered very
high or very low MGS scores (Figure 2). This finding
is in line with our initial validation results—the aMGS
is significantly more accurate when classifying
Table 1. Legend- Images assessed were from our initial training
set. We found that restricting analysis to high confidence images
(P0.75) yielded the highest degree of accuracy while maintaining a
high number of quantifiable images (67% of total images from the
training set). Human prediction values denote images determined
to be “in pain” or “not in pain“ by human assessment. Machine
predictions denote images assessed by the aMGS.
Machine Prediction
Human Prediction (Truth)
Pain (images) No pain Total
Pain 2,159 85 2,224
No pain 226 2,107 2,333




Figure 2. Direct correlation between human and machine gri-
mace scores using novel grimace images. aMGS confidence scores
were placed on a continuous scale, with 1.0 being equal to 100%
confidence that the mouse image was not showing pain and 1.0
being equal to 100% confidence that the mouse image was showing
pain. Resulting aMGS confidence scores were grouped by corre-
sponding human MGS score. Bars represent mean SEM of
transformed aMGS scores. Values significantly different from
chance (**p< 0.01; ***p< 0.0001) according to one-sample t test.
aMGS: automated Mouse Grimace Scale; MGS: Mouse Grimace
Scale. “Chance”= 0.5
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high-confidence “pain” and “no pain” images than
ambiguous images.
The aMGS accurately detects pain and relief of
pain in a post-operative model
We next tested the predictive validity of the aMGS in the
laparotomy assay of post-operative pain. We used
the aMGS to quantify the relative proportion of high-
confidence images scored from mice at baseline with
images taken 60 min after laparotomy or sham surgery.
We compared these groups with a third cohort of
animals that were given carprofen immediately after sur-
gery. Mice filmed after laparotomy surgery produced
significantly more “pain” images than sham surgery or
mice given carprofen during recovery (one-way ANOVA
found a significant main effect of group (F(2,36)=9.7,
p< 0.0001) (Figure 3(a)).
Despite the marked differences in the relative amount
of “pain” images observed between laparotomy and con-
trol groups, we noticed that mice in the sham group also
produced more “pain” images during the post-operative
period. To minimize the possibility of mice falling asleep,
a known confound for mouse grimace scoring, we re-ran
the aMGS on a subset of videos taken from the first
30min following surgery (n¼ 12 mice/condition).
A one-way ANOVA of the results found a similar
main effect by surgery group (F(2,33) =4.0, p¼ 0.03)
with laparotomized mice producing significantly more
“pain” images than shams (Figure 3(b)). Mice given
carprofen following laparotomy showed a decreased
analgesic effect during this abbreviated observation
period after surgery. This finding suggested that the
analgesic was not as effective during the first 30 min
observation period (p¼ 0.07).
Discussion
Using a large number of human-scored images of mouse
faces, obtained from different experimental settings and
across two different labs as a training set, we found that
a machine learning model can accurately classify the
presence of a mouse pain face in a rapid and unbiased
manner when compared to human scoring. Internal val-
idation of the initial (human scored) image training set
revealed that the aMGS was comparable to trained
human coders.5 Furthermore, we observed a high
degree of concordance between the aMGS and human
MGS scores. Although images assigned intermediate
human MGS scores (2 to 4) correspond with relatively
low confidence ratings produced by our model, it is our
experience that these images are of little diagnostic value.
Intermediate MGS scores are assigned when a mouse fails
to clearly demonstrate facial pain in a majority of action
units. Furthermore, by excluding low-confidence images,
the aMGS has a built-in quality control mechanism
whereby low-quality images (i.e., where the face is not
fully captured, is blurred, or includes the face of the adja-
cent mouse) are excluded from analysis. By restricting
image classification to high-confidence ratings, the
aMGS was comparable (94% accuracy) to the most
highly trained human coder in previous studies.5
The aforementioned accuracy values were based on
comparing aMGS output to human MGS scores
across multiple pain assays. We also compared human
scores to aMGS output in a second cohort of mice
undergoing ankle zymosan injections, an assay of
inflammatory pain. We found that our computer
model’s predictions correlated strongly with human
scores across the entire MGS range, yielding a
Pearson’s r¼ 0.75. We further tested the utility of the
aMGS with a post-surgical pain assay. We found that
Figure 3. The aMGS correctly predicted analgesic efficacy in a post-operative pain assay. High-confidence images collected 60 min (a) or
30 min (b) following surgery. Bars represent mean SEM of difference scores (number of pain images after surgery – number of pain
images at baseline). BL: baseline; SHAM: sham surgery; LAP: laparotomized animal; LAPþCAR: laparotomized animal given 50 mg/kg
of the NSAID carprofen immediately following surgery. n¼ 12 to 14 for all conditions. Values *p< 0.05; ***p< 0.001; p¼ 0.074 as
determined by Tukey Test following one-way ANOVA.
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the aMGS classified a significantly larger proportion of
mouse images as being in pain following a laparotomy
procedure than a comparable sham surgical procedure.
Likewise, the aMGS detected significantly less mouse
pain images after mice were administered the analgesic
carprofen immediately following a laparotomy surgery,
suggesting that our aMGS can detect pain-specific
changes in the mouse face following the relief of pain.
We noticed that an increasing number of images from
mice in the sham surgical cohort were scored as “pain”
during the 1-h observation period when compared to
baseline, albeit significantly less than laparotomized ani-
mals (Figure 3(a)). After checking video footage, we
noted that the prolonged, 120-min testing period
resulted in some of our sham animals falling asleep.
An analysis of the first 30 min of behavior following
surgery abrogated this effect, although it also decreased
the effect of the analgesic, which was injected immedi-
ately after surgery and thus may not have had enough
time to reach full efficacy (Figure 3(b)). Based on this
analysis, we determined that our model has difficulty
distinguishing between images of sleeping and grimacing
mice, much like human observers.5 To reduce chances of
animals falling asleep, future experiments would benefit
from shorter observation periods. One additional caveat
of our model is that the current version of the aMGS is
optimized to detect facial grimacing in albino mice.
Further training sets containing non-albino mouse
images will be needed to adapt the aMGS to classify
pain in other strains of mice with agouti or black fur.
Finally, the current version of the aMGS is only able to
provide a binary pain assessment (“pain” or “no pain”)
and a semi-quantitative confidence rating, in contrast to
human scores that can detect subtler changes in mouse
facial expressions.
The successful development of machine learning
applications presents an enormous opportunity for bio-
medical research. Researchers used large data sets (from
previously established diagnostic testing) to train convo-
lutional neural networks to detect human health issues
with a high degree of accuracy, including skin
cancer,29,30 breast cancer,31–34 and thoracic abnormali-
ties.35,36 Like these other automated systems, the aMGS
can be deployed quickly and cheaply as a reliable
replacement for manual MGS scoring, which is relatively
labor intensive, low-throughput, and prone to human
bias. Human efforts to evaluate rodent grimacing in
real-time have so far produced mixed results.37,38 The
aMGS has the potential to be useful for a large
number of applications, providing an objective metric
for pain research, as well as serving as a front-line diag-
nostic for animal pain monitoring. Finally, the through-
put of the aMGS makes possible long-term monitoring
of pain, quickly and accurately assessing the presence of
facial grimace in much larger data sets than previously
described5 and in models of chronic pain.39,40,41
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